This research considers potential dose increase in target due to cisplatin (Pt) concentration and radiation type. Cisplatin concentrations from 0.003 to 120 mM were used. Monte-Carlo simulation of Linear accelerator (Elekta Synergy) and X-ray tube (Xstrahl300) was carried out using Geant4 and PClab. As the first step of this research, we performed simulation of energy spectrum from radiotherapy units (spectrum model). The next step was the modeling of linear accelerator head and X-ray tube, and the distribution of dose in the water phantom (PDD model). At the second stage, dose changes were investigated in the presence of cisplatin in the target (CIS model). The simulation results showed that the dose escalation can be caused by photon-capture therapy (PCT). There is a dose enhancement in the volume where cisplatin is accumulated. Then higher is concentration, then higher is the effect. However, the photon energy increase from 60 to 250 kV and increase of depth of target reduces the effect of PCT due the decrease of the photoelectric effect cross-section. Should be noticed, that the orthovoltage X-rays energy, listed in the table with results shows higher dose enhancement, than the megavoltage photon beam generated from linear acceleration sources. In addition, that the dose enhancement factors (DEF) are higher in linac without flattening filter, than in linac with flattening filter.
Introduction
Radiation therapy is an important and effective option for treatment of malignant tumors [1] . Actual problem of radiotherapy is increasing effectiveness and reducing side effects of the treatment. Binary technologies of radiation therapy can be used to improve treatment results. One of the most promising technology is contrast-enhanced or "photon-capture" radiotherapy (PCT) [2] . The basic principle of PCT is the generation of a large number of the characteristic X-rays and low-energy Auger-electrons due to interaction between photons and nuclei of heavy elements (Z ≥ 53). In biological tissue this secondary low-energy radiation ionizes nearby atoms and leads to the occurrence of highly active radical series, which causes the destruction of the macromolecules of DNA and RNA as well as other cell structures.
The PCT is effective at low X-ray energies where the photoelectric effect dominates (up to about 200 kV) [3] . Accordingly, the energy escalation of photon beams leads to a gradual decrease the effect of the PCT. However, low-energy photons for medium-and deep-seated tumors are limited due to their low penetrating ability. But, these orthovoltage X-rays energy may be used in an intraoperative therapy or to treatments superficial lesions. And for irradiation of deep-seated tumors, the megavoltage photon beams from linear accelerators are widely used, where the Compton effect is maximal and the photoelectric effect is minimal. Although the effect of PCT should be low, different studies show the escalation of energy in the target volume due to the introduction of dose-enhancing agent (DEA) at megavolt photon beams [4, 5, 6] . Some authors suggest that the observed effect is caused by the wide energy spectrum of photon beams, which including the low-energy kilovolt energy range.
In this study the chemotherapeutic drug cisplatin (Cl2H6N2Pt), which contains platinum atoms, was taken as DEA. Cisplatin, a widely used cytostatic drug, causes cell cycle arrest, inhibition and transcription and, ultimately, apoptosis, i.e. cell death [7] . In the chemoradiation method, the use of cisplatin showed that the drug has not only a chemical effect, but also an obvious radiosensitization effect in the tumor [8, 9] .
In this research we simulated the dependence of dose increase on the DEA concentration at 6 and 10 MV medical Linac and orthovoltage X-rays radiation using Monte-Carlo simulation by the means of Geant4.
Materials and methods

Clinical Dosimetry
The percentage depth dose (PDD) curves were measured on the 6 and 10MV linear accelerator (Elekta Synergy, Elekta Ltd.) and X-ray tube (Xstrahl300) with energy 60, 120, 180 and 250 kV (figure 1).
The PDD of Linear accelerator in a water phantom (Blue Phantom, IBA) using ionization chamber CC13(IBA) having a chamber volume was 0.13 cm 3 , was measured with 1 mm step. The source-surface distance (SSD) was 100 cm, the radiation field area was 10×10 cm 2 . And the PDD in a water phantom by 1 mm increments from Xstral300 X-ray tube was measured.
Dose measurements in the energies range from 100 kV to 250 kV using an ionization chamber PPC40 (IBA) having a chamber volume was 0.40 cm 3 , were carried out. The 60 kV energy were measured using the SP34 QA phantom and farmer chamber PTW 23342 having a chamber volume was 0.02 cm 3 . The experimental measurements were compared with that calculated using Monte-Carlo simulation in water.
a. Elekta Synergy linac b. Xstrahl300 X-ray tube Figure 1 . The PDD measurement
Monte-Carlo simulation
Monte-Carlo simulation was carried out using Geant4 version 10 [10] and PClab version 9.9 [11] codes to perform the dose calculation in this research. The first step of this research we performed simulation of energy spectrum from radiotherapy units (spectrum model). The next step is the modeling of head of linear accelerator and X-ray tube and the distribution of dose in the water phantom (PDD model). At the second stage, dose changes were investigated in the presence of cisplatin in the target (CIS model). A total of 1 x 10 8 histories was run in the model's calculation and the statistical uncertainty of the simulation was kept less than 1 %. Figure 2a shows the spectrum model structure considered in this study. Simulated components included: source of electron beams, X-ray target 1mm thick, copper holder below the target 4mm thick and sensitive detector 1nm thick. The source was modeled in a vacuum space. Electron beam was 2 mm in diameter. Accelerated electron beam was bombarded to the tungsten target to produce photon beam. For the nominal 6 MV energy photon beam, the incident electron beam with a mean energy of 6.7 MeV and a Gaussian energy spread of 0. Based on the manufacturer specifications, we simulated the head of the medical linear accelerator Elekta Synergy located at the Tomsk Regional Oncology Centre. Figure The code of PDD simulation from medical linear accelerator was calculation for filtered and flattening filter free (FFF) systems. The distance between the accelerator source and the water phantom surface (SSD) was 100 cm. Square field 10x10 cm 2 were studied. The voxel size of sensitive detector was 0.5x0.5x0.1 cm 3 .
Medical Linac simulation
X-ray tube simulation
In result of interaction between beams of primary particles (electrons) and the tungsten anode of the X-ray tube is generated to bremsstrahlung and characteristic radiation. Energy spectrum of generated X-ray photon beams in detector 1 nm thick was calculated. Figure 3a shows a simulation of the generating x-ray photons (spectrum model). The electron beam is multidirectional point source and diameter is equal to 2.00 mm. The anode is located at an angle of 20 degrees. The model includes a beryllium window 2 mm thick.
At the second stage, the interaction of X-ray photons with water phantoms was simulated to obtain data on depth-dose distributions. Figure 3b shows a simulation of PDD in water phantom (PDD model). The model includes primary filters is half-value layer (HVL), additional filter of various thicknesses, conical applicator and water phantom. Percent depth dose with sensitive ring detector was defined 1 cm radius and 1 mm thick. The PDD with a 1 mm step were scored using detector inside a water phantom with dimensions was 41х47,8 см 2 at the source to surface distance is equal 50 cm for energy more than 100 kV and 30 cm for energy up to 100 kV. The radiation field with a transverse size of 10x10 cm 2 was used. 
Cisplatin simulation (CIS model)
In the next stage of dose change simulation, we performed with the presence of cisplatin in the target volume. Cisplatin concentrations were selected on the basis of acceptable doses that were considered in previous works by the authors and higher to evaluate dose changes from cisplatin concentration [12, 13, 14, 15, 16] , while 0,003 mM is the minimum cisplatin concentration during which there is a visible effect in radiobiological experiments after X-ray irradiation. Cisplatin was injected into the target, which was located at a certain depth of water phantom. A 1 mm, 10 mm, 30 mm and 50 mm depths of target location for X-ray tube simulation and 0.5 mm, 50 mm depths of target location for linac simulation were considered. This allowed us to observe not only the dependence on DEA concentration, but also the dependence on the depth of the target location. The calculations of the сisplatin simulation with DEA was carried out while keeping absolutely everyone the parameters of the PDD model concept.
Results
Spectrum model
The photon energy spectrum as a function of photon energy for linac is shown in figure 6 . The energy spectra of incident photons peak were found at 0.511 MV for the maximum nominal energy is 6 and 10 MV. a) 6MV energy spectrum b) 10MV energy spectrum Figure 6 . The photon beams energy spectrum after X-ray target
The photon beam energy spectra in the tube voltages including 60, 120, 180 and 250 kV by the Geant4 and PClab were calculated. The results are presented in figures 7 to 10. The results for these energies showed a similar mathematical differences between Geant4 and PClab calculations. The small differences can be associated to the different algorithms and crosssection files used for different systems. Nevertheless, the results confirmed that spectrum model is accurate and can be used for dose distribution calculations in water phantom.
Percentage depth dose mode l
The PDD obtained by simulations were compared with experimental data obtained with the linear accelerator Elekta Synergy in a Tomsk Regional Oncology Center. The PDD for the 10x10 cm2 irradiation area is shown in figure 11 
CIS model
In the next stage the simulation of dose change we performed in the presence of cisplatin in the target volume at Linac and X-ray tube irradiation. Table 1 -5 presents the dose-enhancing factor (DEF) for different depth target location and different cisplatin concentration were calculated by Geant4 and PClab. Each of the cases in this table that the no DEA outside the tumor volume was supposed. It's in order to provide a clear relationship between the DEA concentration and beam energy.
The dose enhancement factors (DEF), defined as the ratio of the dose in the tumor volume ( with DEA to that dose in the tumor without DEA ( :
In case of linear accelerator simulation the 5 and 50 mm depths of target location and energy photon beam to 6 MV and 10 MV were considered. This allowed us to observe not only the dependence on agent concentration, but also the dependence on the depth of the target location and energy of photons. In addition, linac without a flattening filter (FFF) were considered. The table 1 shows the dose-enhancing factor for reference points at linacs with flattening filter and flattening filter free (FFF).
As a result, the DEFs calculation for linac does not observe clinically important dose increase. At a concentration of 120 mM, a dose increase of up to 7.7 % and 3.1 % is observed for 6 MV and 10 MV correspondingly. As well as studies of flattening filter free showed the DEF increase equal to 8.6 % and 8.9 % when irradiated with a photon beams of 6 and 10 MV (Figure 18 ). In case of X-ray tube the 1 mm, 10 mm, 30 mm and 50 mm depths of target location and energy photon beam equal to 60, 120, 180 and 250 kV were considered. The tables 2-5 shows the DEF for reference points. From the tables it can be noted, that the DEF increases for higher values in the presence of the cisplatin. There is a dose enhancement in the volume where cisplatin is accumulated. The higher is concentration, the higher is the effect. However, the photon energy increase from 60 to 250 kV reduces the effect of PCT due the decrease of the photoelectric effect cross-section. The highest DEF value is observed when irradiated with 60 kV x-ray. The graph 19 shows a linear increase of DEF at increasing concentration. Based on the orthovoltage X-rays energy considered, the highest degree of dose enhancement occurs for 60 kV and higher DEA concentration. According to the graph, that in the field of DEA accumulation there is a sharp increase in dose not only for surface targets, but also for deeply targets located. For example, in the case of the cisplatin presence in the target and irradiation by a photon beams with an energy of 250 kV a dose accumulation is higher than when irradiated with photon beams with an energy of MV and 1.25 MV(Co-60), and even at a depth target location of 5 cm is observed.
Conclusion
This research considers potential dose increase in target due to cisplatin (Pt) concentration and radiation type. In general, Monte-Carlo results showed that dose escalation in target at orthovoltaic xray and megavolt photon beams can be due photon-capture therapy. For X-rays photon beams the DEF was higher than for megavoltage photon beam generated from linear acceleration. For 60 kV x-rays, a tremendous DEF was seen, ranging of almost 4.3 at the highest Pt concentration. The dose enhancement is somewhat less for with increasing energy up to 250 kV. These differences become important with very high DEA concentrations to 120 mM in tumor.
We should also notice, that the DEF is higher in linacs without flattening filter than in linacs with flattening filter. For the 6 and 10 MV photon beams with flattening filter the DEF to 1.077 and 1.031 was seen. As well as 6 and 10 MV without flattening filter -DEF equal to 1.086 and 1.089 was observed. It can be assumed that this phenomenon is due to a cause that the flattening filter system absorbs low-energy photon beam. The same time these low-energy photons cause a photoelectric effect in FFF systems and corresponding dose increase in the target is observed.
Perhaps from the point of view of сlinical significance the DEF values obtained for the 6 and 10 MV are not important. However, from the point of view of considering the error of dose adjustment these factors can be taken into account, for example, with simultaneous chemoradiation treatment or the other DEA introduction.
This way, Monte-Carlo simulation showed that the dose-enhancing factor increases for higher values of cisplatin concentrations and lower photon energy.
